Bruder, Joseph T.
Regenxbio (United States)
3 papers on CoChat
Most cited papers
- Verified
Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectors
Hollidge, B. S., Carroll, H. B., Qian, R., Fuller, M. L., Giles, A. R., Mercer, A. C., Danos, O., Liu, Y., Bruder, J. T., & Smith, J. B. (2022) · Frontiers in Neurology
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 45
- Verified
Sex Difference Leads to Differential Gene Expression Patterns and Therapeutic Efficacy in Mucopolysaccharidosis IVA Murine Model Receiving AAV8 Gene Therapy
Piechnik, M., Amendum, P. C., Sawamoto, K., Stapleton, M., Khan, S., Fnu, N., Álvarez, V., Pachon, A. M. H., Danos, O., Bruder, J. T., et al. (2022) · International Journal of Molecular Sciences
Lysosomal Storage Disorders ResearchVirus-based gene therapy research
Cited by 28
- Verified
The presence of CpGs in AAV gene therapy vectors induces a plasmacytoid dendritic cell-like population very early after administration
Glenn, J. D., Negash, H., Henry, W., Qian, R., Liu, Y., Danos, O., Bruder, J. T., & Karumuthil-Melethil, S. (2024) · Cellular Immunology
Virus-based gene therapy researchImmunotherapy and Immune Responses
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free